activity
20162023
most citedA scalable solver for a stochastic, hybrid cellular automaton model of personalized breast cancer therapy

9 citations · 13 across the 5 of their papers we have counts for

collaborators

5 papers

q-bio.PE2023

Using birth-death processes to infer tumor subpopulation structure from live-cell imaging drug screening data

C. Wu, E. B. Gunnarsson, E. M. Myklebust +6

Tumor heterogeneity is a complex and widely recognized trait that poses significant challenges in developing effective cancer therapies. In particular, many tumors harbor a variety…

math.OC2023

Modeling of mouse experiments suggests that optimal anti-hormonal treatment for breast cancer is diet-dependent

Tuğba Akman, Lisa M. Arendt, Jürgen Geisler +3

Estrogen receptor positive breast cancer is frequently treated with anti-hormonal treatment such as aromatase inhibitors (AI). Interestingly, a high body mass index has been shown…

stat.AP2021

ABC of the Future

Henri Pesonen, Umberto Simola, Alvaro Köhn-Luque +8

Approximate Bayesian computation (ABC) has advanced in two decades from a seminal idea to a practically applicable inference tool for simulator-based statistical models, which are…

q-bio.QM2021★ 9 cited

A scalable solver for a stochastic, hybrid cellular automaton model of personalized breast cancer therapy

Xiaoran Lai, Håkon A. Taskén, Torgeir Mo +4

Mathematical modeling and simulation is a promising approach to personalized cancer medicine. Yet, the complexity, heterogeneity and multi-scale nature of cancer pose significant c…

q-bio.TO2016★ 4 cited

Why one-size-fits-all vaso-modulatory interventions fail to control glioma invasion: in silico insights

J. C. L. Alfonso, A. Kohn-Luque, T. Stylianopoulos +3

There is an ongoing debate on the therapeutic potential of vaso-modulatory interventions against glioma invasion. Prominent vasculature-targeting therapies involve functional tumou…